AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19578224
Drug: Daily chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily chemotherapy
Trial: 11823073
Drug: Double-bolus eptifibatide
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double-bolus eptifibatide 180/90 (30 min apart) and 1.33 microg/kg per min infusion with 50 mg t-PA (Group I)
Trial: 11823073
Drug: Double-bolus eptifibatide
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double-bolus eptifibatide 180/90 (10 min apart) and 2.0 microg/kg per min infusion with 50 mg t-PA (Group II)
Trial: 7486271
Drug: Nicardipine 0.016
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 0.016 mg.kg‐1
Trial: 7486271
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate 50 mg.kg‐1
Trial: 2298002
Drug: High intravenous
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High intravenous glucose infusion
Trial: 2298002
Drug: Low intravenous
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intravenous glucose infusion
Trial: 25943183
Drug: Group P2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group P2: intravenous flurbiprofen before surgery and epidural fentanyl + ketamine after surgery
Trial: 7635032
Drug: Antiepileptic drugs
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic drugs
Trial: 7840398
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of beta-blockers and calcium channel blockers
Trial: 29337835
Drug: Promethazine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine (0.3 mg/kg)
Trial: 28219442
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg orally once daily for 24 months
Trial: 22830537
Drug: Acid treatment
RxNorm normalized name: SALICYLIC ACID 20 mg in 1 mL TOPICAL GEL [Skin Laundry. Clean Slate Exfoliating 2 Salicylic Acid Treatment Gel Cleanser Cleanse Exfoliate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acid treatment with methacrylate resin composite
Trial: 23031319
Drug: Commercial attenuated
RxNorm normalized name: varicella, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial attenuated vaccines
Trial: 23031319
Drug: Experimental heterologous
RxNorm normalized name: Human heterologous liver cells
DrugBank: Heterologous human adult liver derived progenitor cells (DB17695)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental heterologous (LV) inactivated vaccine
Trial: 23031319
Drug: Commercial inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial inactivated vaccine
Trial: 23031319
Drug: Experimental homologous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental homologous (08 V194) inactivated vaccine
Trial: 23031319
Drug: Experimental heterologous
RxNorm normalized name: Human heterologous liver cells
DrugBank: Heterologous human adult liver derived progenitor cells (DB17695)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental heterologous (07 V063 and LV) inactivated vaccines
Trial: 23575220
Drug: Griseofulvin 25
RxNorm normalized name: griseofulvin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Griseofulvin 25 mg/kg/day
Trial: 23575220
Drug: Fluconazole 4
RxNorm normalized name: fluconazole 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 4 mg/kg/day
Trial: 23575220
Drug: Fluconazole 6
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 6 mg/kg/day
Trial: 17584749
Drug: Cognitive-behavioural group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural group treatment (CBT), n = 19
Trial: 8606536
Drug: Extended-release felodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release felodipine (10 mg once daily)
Trial: 8606536
Drug: Slow-release nifedipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release nifedipine (20 mg twice daily)
Trial: 361349
Drug: Glucamethacin (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucamethacin (420 mg/day)
Trial: 25079375
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of a mixture of two dimeticones of low viscosity (NYDA)
Trial: 25079375
Drug: 0.05% solution
RxNorm normalized name: Equate Nasal Spray 0.05% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% solution of KMnO4
Trial: 18036292
Drug: Shenfu injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu injection (20 ml/L added to blood containing cardioplegic liquid)
Trial: 6805791
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic prophylaxis
Trial: 28835268
Drug: Preoperative antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative antibiotic prophylaxis (2000 mg of first-generation cephalosporin delivered intravenously)
Trial: 24035939
Drug: Garlic tablets
DrugBank: Garlic (DB10532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic tablets at 600 mg
Trial: 24035939
Drug: Garlic tablets
DrugBank: Garlic (DB10532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic tablets at 1200 mg
Trial: 21242022
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment with exercise programme
Trial: 12711266
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive treatment for pathological gambling
Trial: 16138577
Drug: Clinical treatment
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical treatment for patients with aberrant sperm nuclear proteins (n=30)
Trial: 10077290
Drug: Manual-assisted cognitive-behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual-assisted cognitive-behaviour therapy (MACT)
Trial: 6628517
Drug: Ketanserin 40
RxNorm normalized name: ketanserin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 40 mg twice daily
Trial: 3101865
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg twice daily
Trial: 7032304
Drug: Gentamicin sulfate
RxNorm normalized name: Gentamicin Sulfate
DrugBank: Gentamicin (DB00798)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gentamicin sulfate ophthalmic solution
Trial: 27696593
Drug: Inappropriate shock
RxNorm normalized name: house dust allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inappropriate shock therapy
Trial: 27696593
Drug: Appropriate shock
RxNorm normalized name: house dust allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Appropriate shock therapy
Trial: 26072346
Drug: Patching (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patching (3 hours daily for 5 months, followed by 1 month of no patching)
Trial: 15281513
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine (0.125 mg/kg)
Trial: 15281513
Drug: codeine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: codeine (1 mg/kg)
Trial: 15281513
Drug: tramadol (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tramadol (1.25 mg/kg)
Trial: 15281513
Drug: placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (10 mL 0.9% w/v sodium chloride)
Trial: 11199953
Drug: amisulpride 400
RxNorm normalized name: amisulpride 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amisulpride 400 mg/day (N = 12)
Trial: 11199953
Drug: olanzapine 20
RxNorm normalized name: olanzapine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: olanzapine 20 mg/day (N = 13)
Trial: 11199953
Drug: sertindole 12
RxNorm normalized name: sertindole 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sertindole 12 mg/day (N = 13)
Trial: 11199953
Drug: clozapine 100
RxNorm normalized name: clozapine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clozapine 100 mg/day (N = 13)
Trial: 9449585
Drug: Betanecholchloride (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betanecholchloride (50 mg three times a day from the 3rd postoperative day)
Trial: 9449585
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received betanecholchloride only if residual urine persisted above 50 ml after the 10th postoperative day)
Trial: 31201809
Drug: Uterosacral ligament
RxNorm normalized name: human ligament preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterosacral ligament suspension
Trial: 26715658
Drug: Outside brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outside brachial plexus sheath injection
Trial: 26420240
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy with low-level laser therapy (protocol B)
Trial: 26420240
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (protocol A)
Trial: 23103498
Drug: BQ-123 (endothelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BQ-123 (endothelin type A receptor antagonist)
Trial: 21968662
Drug: Tazarotene gel
RxNorm normalized name: Tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene gel (0.1%) pretreatment for one week before ALA PDT
Trial: 21968662
Drug: Tazarotene gel
RxNorm normalized name: Tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene gel (0.1%) pretreatment
Trial: 10916529
Drug: Inhaled beclomethasone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone, mean daily dose of 2861 micrograms/day, decreasing during treatment.
Trial: 9423108
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg/kg)
Trial: 9725754
Drug: Lorazepam 0.026
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 0.026 mg/kg
Trial: 9725754
Drug: Lorazepam 0.038
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 0.038 mg/kg
Trial: 29752604
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dexamethasone submucosally
Trial: 27430336
Drug: Weekly care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly care management phone calls (CMPCs)
Trial: 22561875
Drug: Rasagiline 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 2 mg/d
Trial: 24919813
Drug: Rasagiline 1
RxNorm normalized name: rasagiline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 1 mg/d
Trial: 8688340
Drug: Continuous tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous tamoxifen therapy beyond 5 years
Trial: 7740638
Drug: Stroke unit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stroke unit treatment
Trial: 1505614
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg tid for 6 days (young subjects)
Trial: 1427426
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy (hydroxyurea)
Trial: 22289904
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg/kg body weight) 4 hours before cardiopulmonary bypass
Trial: 15929755
Drug: Non-eradication group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-eradication group (no treatment for H. pylori)
Trial: 12628815
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose (3.3 microg) of TBE vaccine
Trial: 10656156
Drug: Group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group treatment based on psychosomatic and physio-therapeutical principles, cognitive and operant behavioral therapy, 2.5 hours per week for 10 weeks.
Trial: 25641731
Drug: Aspirin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (600 mg)
Trial: 22481427
Drug: MF59-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted vaccine containing 3.75 μg A/H1N1 antigen
Trial: 22481427
Drug: MF59-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted vaccine containing 7.5 μg A/H1N1 antigen
Trial: 22481427
Drug: Nonadjuvanted vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted vaccine containing 15 μg A/H1N1 antigen
Trial: 17666715
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: Infusion of 0.025 to 0.1 microg x kg(‐1) x min(‐1) with a PCA bolus of 0.25 microg x kg(‐1)
Trial: 17666715
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: Infusion of 0.025 microg x kg(‐1) x min(‐1) with a PCA bolus increased from 0.25 to 1 microg x kg(‐1)
Trial: 15469647
Drug: Probiotic (6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic (6.5 x 10(9) Lactobacillus casei Shirota cells twice daily)
Trial: 15469647
Drug: Prebiotic (lactulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic (lactulose 10 g twice daily)
Trial: 8659199
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg/day
Trial: 12888781
Drug: Cyproheptadine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproheptadine (4 mg)
Trial: 3511127
Drug: Cromolyn-like agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn-like agent administered via a Nebulizer Chronolog, used four times a day for 12 weeks
Trial: 3511127
Drug: Cromolyn-like agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn-like agent
Trial: 31310464
Drug: Intermittent hypothermic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent hypothermic blood solution
Trial: 24613817
Drug: Meeting treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meeting treatment targets for HbA1c, cholesterol, and blood pressure
Trial: 350506
Drug: Previous formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previous formulation
Trial: 30390639
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment without music (Control)
Trial: 22318191
Drug: 20-mg long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg long-acting methylphenidate
Trial: 20973316
Drug: Control (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (250 mL of water)
Trial: 17722615
Drug: Solifenacin 10
RxNorm normalized name: solifenacin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin 10 mg/day
Trial: 8859935
Drug: placebo p.o.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo p.o. + perindopril at 0.167 mg i.v. (day 1) and perindopril 2 mg p.o. (day 2)
Trial: 8859935
Drug: enalapril 2.5
RxNorm normalized name: enalapril 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril 2.5 mg p.o.
Trial: 8859935
Drug: perindopril 2
RxNorm normalized name: perindopril 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: perindopril 2 mg p.o.
Trial: 8859935
Drug: enalapril therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril therapy
Trial: 26728982
Drug: High-dose Shaoyao
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Shaoyao Shujin tablet
Trial: 26728982
Drug: Low-dose Shaoyao
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Shaoyao Shujin tablet
Trial: 20929121
Drug: Kunning Oral
RxNorm normalized name: CAMPHOR (SYNTHETIC) 9 g in 100 mL / METHYL SALICYLATE 5 g in 100 mL / MENTHOL 39 g in 100 mL / TURPENTINE OIL 18 g in 100 mL TOPICAL OIL [Chan Yat Hing She Kun Wool Lok Medicated Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kunning Oral Liquid (Control)
Trial: 9661555
Drug: Epidural ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ketamine 60 mg administered before induction of anesthesia (Group 1)
Trial: 9661555
Drug: Epidural ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ketamine 60 mg administered after the parietal peritoneum was closed (Group 2)
Trial: 2598905
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg caffeine ingested at 2315 h
Trial: 1103897
Drug: i.v. and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. and oral application of AR-DF 26
Trial: 31283892
Drug: Combination CPP-ACP-cranberry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination CPP-ACP-cranberry dentifrice
Trial: 25677596
Drug: Tenecteplase 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenecteplase 0.1 mg/kg
Trial: 19384673
Drug: Solifenacin flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin flexible dosing (5-10 mg)
Trial: 19384673
Drug: Tolterodine 4
RxNorm normalized name: tolterodine 4 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 4 mg sustained release (SR)
Trial: 19384673
Drug: Placebo (assumed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (assumed to be comparable to no treatment)
Trial: 11336584
Drug: Proton-pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton-pump inhibitor (PPI)-based triple therapy for 1 week
Trial: 11336584
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate (RBC)-based triple therapy (PPI or RBC plus any two of metronidazole, amoxycillin, and clarithromycin) for 1 week
Trial: 11336584
Drug: RBC-triple therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC-triple therapy for resistant strains
Trial: 11336584
Drug: General treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General treatment regimens
Trial: 7819706
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg daily injections of intramuscular progesterone from days 2 to 14 after TVA
Trial: 2891940
Drug: Oral mexiletine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mexiletine (10 mg/kg bodyweight daily)
Trial: 31442495
Drug: 250-μg patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250-μg patch (epicutaneous immunotherapy for peanut allergy)
Trial: 23179351
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg nickel chloride
Trial: 19637959
Drug: Routine replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine replacement of peripheral intravenous catheters at 72-96 hours
Trial: 15282457
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of protamine sulphate (25 mg/h for 6 hours)
Trial: 10325668
Drug: Granisetron (GR)
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron (GR) 1 mg
Trial: 10325668
Drug: Prochlorperazine (PCh)
RxNorm normalized name: Prochlorperazine
DrugBank: Prochlorperazine (DB00433)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prochlorperazine (PCh) 10 mg
Trial: 1680533
Drug: Azelastine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine (8 mg)
Trial: 6412508
Drug: Penicillin-V, 55
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin-V, 55 mg/kg/day for two days
Trial: 6412508
Drug: Penicillin-V, 55
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin-V, 55 mg/kg/day for seven days
Trial: 25114127
Drug: KAE609 (Cipargamin)
RxNorm normalized name: Cipargamin
DrugBank: Cipargamin (DB12306)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAE609 (Cipargamin) 1 to 300 mg single dose
Trial: 25114127
Drug: KAE609 (Cipargamin)
RxNorm normalized name: Cipargamin
DrugBank: Cipargamin (DB12306)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAE609 (Cipargamin) 10 to 150 mg once daily for 3 days
Trial: 22212720
Drug: Timothy immunotherapy
RxNorm normalized name: Timothy
DrugBank: Phleum pratense top (DB14179)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timothy immunotherapy
Trial: 7697274
Drug: Mite immunotherapy
RxNorm normalized name: House dust mite immunotherapy extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mite immunotherapy
Trial: 28714728
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) plus contingency management (CM)
Trial: 9005798
Drug: Ofloxacin administered
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin administered intravenously in a dose of 200 mg twice a day followed by oral use in the form of tablets in a dose of 200 mg twice a day for 5 to 6 days.